Regencell Bioscience Ownership 2024 | Who Owns Regencell Bioscience Now?

OverviewChart

Institutional Ownership

0.01%

Insider Ownership

88.76%

Retail Ownership

11.23%

Institutional Holders

3.00

Regencell Bioscience Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UBS GROUP AG	0.00%	-	312	-1,088	-77.71%	1,048	Jun 30, 2024
BLACKROCK INC.	0.00%	-	238	-	-	800	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.00%	-	13	-	-	44	Jun 30, 2024

Regencell Bioscience's largest institutional shareholder is UBS GROUP AG, holding 0.00% of the company's total share outstanding, currently valued at $1.05K. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UBS GROUP AG	0.00%	-	312	-1,088	-77.71%	1,048	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.00%	-	13	-	-	44	Jun 30, 2024
BLACKROCK INC.	0.00%	-	238	-	-	800	Jun 30, 2024

The largest Regencell Bioscience shareholder by % of total assets is UBS GROUP AG. The company owns 312.00 shares of Regencell Bioscience (RGC), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BLACKROCK INC.	0.00%	-	238	-	-	800	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.00%	-	13	-	-	44	Jun 30, 2024
UBS GROUP AG	0.00%	-	312	-1,088	-77.71%	1,048	Jun 30, 2024

As of Jun 30 2024, Regencell Bioscience's largest institutional buyer is BLACKROCK INC.. The company purchased 0.00 stocks of RGC, valued at $800.00.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UBS GROUP AG	0.00%	-	312	-1,088	-77.71%	1,048	Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.00%	-	13	-	-	44	Jun 30, 2024
BLACKROCK INC.	0.00%	-	238	-	-	800	Jun 30, 2024

As of Jun 30 2024, Regencell Bioscience's biggest institutional seller is UBS GROUP AG. The company sold -1.09K shares of RGC, valued at $1.05K.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Regencell Bioscience Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
Gabelli Gold Fund, Inc.	4.75%	3,650,000	-	-	Dec 29, 2023
AMERICAN CENTURY ETF TRUST	0.00%	100	-	-	Feb 29, 2024

Regencell Bioscience's largest mutual fund holder by % of total assets is "Gabelli Gold Fund, Inc.", owning 3.65M shares, compromising 4.75% of its total assets.

Regencell Bioscience Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 24	3	-
31 Dec, 23	3	-25.00%
30 Sep, 23	4	100.00%
30 Jun, 23	2	-50.00%
31 Mar, 23	4	33.33%
31 Dec, 22	3	-40.00%
30 Sep, 22	5	-
30 Jun, 22	5	25.00%
31 Mar, 22	4	100.00%
31 Dec, 21	2	-33.33%
30 Sep, 21	3	-

As of 31 Mar 24, 3 institutions are holding Regencell Bioscience's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 24	1,651	-89.87%
31 Dec, 23	16,304	2362.84%
30 Sep, 23	662	22.82%
30 Jun, 23	539	-26.77%
31 Mar, 23	736	-38.05%
31 Dec, 22	1,188	-85.51%
30 Sep, 22	8,201	-3.56%
30 Jun, 22	8,504	-57.99%
31 Mar, 22	20,245	188.88%
31 Dec, 21	7,008	-49.85%
30 Sep, 21	13,973	-

Regencell Bioscience (RGC) has 1.65K shares outstanding as of 31 Mar 24, down -89.87% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 24	0.01%	80.85%
31 Dec, 23	0.13%	460128.85%
30 Sep, 23	0.01%	28562.79%
30 Jun, 23	0.00%	12625.86%
31 Mar, 23	0.01%	6590.43%
31 Dec, 22	0.01%	223.27%
30 Sep, 22	0.06%	1432.99%
30 Jun, 22	0.07%	262.40%
31 Mar, 22	0.16%	5214.44%
31 Dec, 21	0.06%	453.85%
30 Sep, 21	0.11%	-

As of 31 Mar 24, Regencell Bioscience is held by 0.01% institutional shareholders, representing a 80.85% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 24	-	-100.00%
31 Dec, 23	1	-66.67%
30 Sep, 23	3	200.00%
30 Jun, 23	1	-50.00%
31 Mar, 23	2	-
31 Dec, 22	2	100.00%
30 Sep, 22	1	-80.00%
30 Jun, 22	5	25.00%
31 Mar, 22	4	100.00%
31 Dec, 21	2	-33.33%
30 Sep, 21	3	-

- institutional shareholders have increased their position in RGC stock as of 31 Mar 24 compared to 1 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 24	1	-
31 Dec, 23	-	-
30 Sep, 23	-	-
30 Jun, 23	-	-100.00%
31 Mar, 23	1	-
31 Dec, 22	-	-100.00%
30 Sep, 22	2	-
30 Jun, 22	-	-
31 Mar, 22	-	-
31 Dec, 21	-	-
30 Sep, 21	-	-

1 institutional shareholders have reduced their position in RGC stock as of 31 Mar 24 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 24	3	-	1,651	-89.87%	0.01%	80.85%	-	-100.00%	1	-
31 Dec, 23	3	-25.00%	16,304	2362.84%	0.13%	460128.85%	1	-66.67%	-	-
30 Sep, 23	4	100.00%	662	22.82%	0.01%	28562.79%	3	200.00%	-	-
30 Jun, 23	2	-50.00%	539	-26.77%	0.00%	12625.86%	1	-50.00%	-	-100.00%
31 Mar, 23	4	33.33%	736	-38.05%	0.01%	6590.43%	2	-	1	-
31 Dec, 22	3	-40.00%	1,188	-85.51%	0.01%	223.27%	2	100.00%	-	-100.00%
30 Sep, 22	5	-	8,201	-3.56%	0.06%	1432.99%	1	-80.00%	2	-
30 Jun, 22	5	25.00%	8,504	-57.99%	0.07%	262.40%	5	25.00%	-	-
31 Mar, 22	4	100.00%	20,245	188.88%	0.16%	5214.44%	4	100.00%	-	-
31 Dec, 21	2	-33.33%	7,008	-49.85%	0.06%	453.85%	2	-33.33%	-	-
30 Sep, 21	3	-	13,973	-	0.11%	-	3	-	-	-

Regencell Bioscience Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Feb 28, 2018	ANSCHUTZ PHILIP F	10 percent owner	-	D-Return	Sell	12,440,000	$23.00	$286.12M	-
Feb 28, 2018	ANSCHUTZ PHILIP F	10 percent owner	-	D-Return	Sell	23,708,639	$23.00	$545.30M	-
Feb 28, 2018	CAMPBELL MICHAEL L	director	-	D-Return	Sell	703,660	$23.00	$16.18M	-
Feb 28, 2018	YEMENIDJIAN ALEX	director	-	D-Return	Sell	21,880	$23.00	$503.24K	-
Feb 28, 2018	TYRRELL JACK	director	-	D-Return	Sell	136,684	$23.00	$3.14M	-
Feb 28, 2018	THOMAS LEE M	director	-	D-Return	Sell	46,585	$23.00	$1.07M	-
Feb 28, 2018	KEYTE DAVID H	director	-	D-Return	Sell	5,767	$23.00	$132.64K	-
Feb 28, 2018	KAPLAN STEPHEN A	director	-	D-Return	Sell	161,033	$23.00	$3.70M	-
Feb 28, 2018	Brymer Charles E	director	-	D-Return	Sell	75,777	$23.00	$1.74M	-
Feb 28, 2018	BELL THOMAS D JR	director	-	D-Return	Sell	132,400	$23.00	$3.05M	-
Feb 28, 2018	BRANDOW PETER B	officer	EVP, General Counsel, Sec.	D-Return	Sell	236,515	$23.00	$5.44M	-
Feb 28, 2018	Ownby David	officer	EVP, CFO and Treasurer	D-Return	Sell	256,761	$23.00	$5.91M	-
Feb 28, 2018	DUNN GREGORY W	officer	President and COO	D-Return	Sell	98,400	$23.00	$2.26M	-
Feb 28, 2018	MILES AMY E	director, officer	Chief Executive Officer	D-Return	Sell	740,753	$23.00	$17.04M	-
Jan 30, 2018	BRANDOW PETER B	officer	EVP, General Counsel, Sec.	F-InKind	Sell	1,283	$22.95	$29.44K	219,217
Jan 30, 2018	Ownby David	officer	EVP, CFO and Treasurer	F-InKind	Sell	1,440	$22.95	$33.05K	237,345
Jan 30, 2018	DUNN GREGORY W	officer	President and COO	F-InKind	Sell	1,738	$22.95	$39.89K	74,971

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Feb 28, 2018	ANSCHUTZ PHILIP F	10 percent owner	-	D-Return	Sell	12,440,000	$23.00	$286.12M	-
Feb 28, 2018	ANSCHUTZ PHILIP F	10 percent owner	-	D-Return	Sell	23,708,639	$23.00	$545.30M	-
Feb 28, 2018	CAMPBELL MICHAEL L	director	-	D-Return	Sell	703,660	$23.00	$16.18M	-
Feb 28, 2018	YEMENIDJIAN ALEX	director	-	D-Return	Sell	21,880	$23.00	$503.24K	-
Feb 28, 2018	TYRRELL JACK	director	-	D-Return	Sell	136,684	$23.00	$3.14M	-
Feb 28, 2018	THOMAS LEE M	director	-	D-Return	Sell	46,585	$23.00	$1.07M	-
Feb 28, 2018	KEYTE DAVID H	director	-	D-Return	Sell	5,767	$23.00	$132.64K	-
Feb 28, 2018	KAPLAN STEPHEN A	director	-	D-Return	Sell	161,033	$23.00	$3.70M	-
Feb 28, 2018	Brymer Charles E	director	-	D-Return	Sell	75,777	$23.00	$1.74M	-
Feb 28, 2018	BELL THOMAS D JR	director	-	D-Return	Sell	132,400	$23.00	$3.05M	-
Feb 28, 2018	BRANDOW PETER B	officer	EVP, General Counsel, Sec.	D-Return	Sell	236,515	$23.00	$5.44M	-
Feb 28, 2018	Ownby David	officer	EVP, CFO and Treasurer	D-Return	Sell	256,761	$23.00	$5.91M	-
Feb 28, 2018	DUNN GREGORY W	officer	President and COO	D-Return	Sell	98,400	$23.00	$2.26M	-
Feb 28, 2018	MILES AMY E	director, officer	Chief Executive Officer	D-Return	Sell	740,753	$23.00	$17.04M	-
Jan 30, 2018	BRANDOW PETER B	officer	EVP, General Counsel, Sec.	A-Award	Buy	17,298	-	-	236,515
Jan 30, 2018	BRANDOW PETER B	officer	EVP, General Counsel, Sec.	F-InKind	Sell	1,283	$22.95	$29.44K	219,217
Jan 30, 2018	Ownby David	officer	EVP, CFO and Treasurer	A-Award	Buy	19,416	-	-	256,761
Jan 30, 2018	Ownby David	officer	EVP, CFO and Treasurer	F-InKind	Sell	1,440	$22.95	$33.05K	237,345
Jan 30, 2018	DUNN GREGORY W	officer	President and COO	A-Award	Buy	23,429	-	-	98,400
Jan 30, 2018	DUNN GREGORY W	officer	President and COO	F-InKind	Sell	1,738	$22.95	$39.89K	74,971

The last insider sell of Regencell Bioscience's stock was made by ANSCHUTZ PHILIP F on Feb 28 2018, selling 12,440,000 shares at $23.00 per share (valued at $286.12M).

Regencell Bioscience Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio

Regencell Bioscience Peer Ownership

Ticker	Company
ANIP	ANI Pharmaceuticals, Inc.
COSM	Cosmos Health Inc.
PAHC	Phibro Animal Health Corporation
SSIC	Silver Spike Investment Corp.
ACRX	Talphera, Inc.
PROC	Procaps Group S.A.
PBH	Prestige Consumer Healthcare Inc.
COLL	Collegium Pharmaceutical, Inc.
HEXO	HEXO Corp.
EGRX	Eagle Pharmaceuticals, Inc.

RGC Ownership FAQ

Who Owns Regencell Bioscience?

Regencell Bioscience is owned by institutional shareholders (0.01%), insiders (88.76%), and public (11.23%). The largest institutional shareholder of Regencell Bioscience is UBS GROUP AG (0.00% of total shares) and the top mutual fund owner is Gabelli Gold Fund, Inc. (4.75% of total shares).

Who are the major institutional shareholders of Regencell Bioscience?

Regencell Bioscience's major institutional shareholders are UBS GROUP AG, BLACKROCK INC., and QUBE RESEARCH & TECHNOLOGIES LTD. The top five shareholders own together 0.00% of the company's share outstanding.

How many Regencell Bioscience shareholders are there?

As of Mar 2024, there are 3 institutional shareholders of Regencell Bioscience.

What percentage of Regencell Bioscience is owned by UBS GROUP AG?

UBS GROUP AG owns 312 shares of Regencell Bioscience, representing 0.00% of the company's total shares outstanding, valued at $1.05K (as of Jun 2024).

What percentage of Regencell Bioscience is owned by BLACKROCK INC?

As of Jun 2024, BLACKROCK INC holds 238 shares of Regencell Bioscience (RGC), compromising 0.00% of the company, valued at $800.

What percentage of Regencell Bioscience is owned by QUBE RESEARCH & TECHNOLOGIES LTD?

QUBE RESEARCH & TECHNOLOGIES LTD is the third largest holder of Regencell Bioscience. The company owns 13 of the company's shares outstanding (worth $44).